Abstract
An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Letters in Organic Chemistry
Title:Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition
Volume: 10 Issue: 5
Author(s): Fuchun Xie, Bingbing X. Li and Xiangshu Xiao
Affiliation:
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Abstract: An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Export Options
About this article
Cite this article as:
Xie Fuchun, Li Bingbing X. and Xiao Xiangshu, Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition, Letters in Organic Chemistry 2013; 10 (5) . https://dx.doi.org/10.2174/1570178611310050014
DOI https://dx.doi.org/10.2174/1570178611310050014 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An <i>In vivo</i> Immunohistochemical Study on MacroH2A.1 in Lung and Lymph-Node Tissues Exposed to an Asbestiform Fiber
Current Molecular Medicine Recent Developments in Taxane Drug Delivery
Current Drug Delivery Combined Anticancer Therapies: An Overview of the Latest Applications
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Alpinia officinarum
Mini-Reviews in Medicinal Chemistry Cancer Metastasis Treatments
Current Drug Therapy Novel Molecules Targeting Dyslipidemia and Atherosclerosis
Current Medicinal Chemistry Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations
Current Medicinal Chemistry Treatment for Radiation-Induced Pulmonary Late Effects: Spoiled for Choice or Looking in the Wrong Direction?
Current Drug Targets Inflammatory Potential of Diet and the Risk of Prostate Cancer: A Casecontrol Study in the West of Iran
Current Nutrition & Food Science Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry Hyaluronic Acid: Targeting Immune Modulatory Components of the Extracellular Matrix in Atherosclerosis
Current Medicinal Chemistry The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review
Current Stem Cell Research & Therapy A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies
Current Bioactive Compounds In Vivo Monitoring of Cell Based Therapy in the Liver
Current Molecular Imaging (Discontinued) Nano-Oncologicals: Regulatory Aspects and Safety Issues
Applied Clinical Research, Clinical Trials and Regulatory Affairs Mechanism and Inhibition of Matrix Metalloproteinases
Current Medicinal Chemistry An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer
Recent Patents on Nanotechnology Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
Current Drug Targets